By proceeding, you agree to our Terms of Use and Privacy Policy.
Drug Discovery Chemistry is a dynamic conference for medicinal and biophysical chemists working in pharma, biotech, and academia. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's personal interests by going back and forth among concurrent tracks. New for 2023 is coverage of targeting transcription factors, plus greatly expanded coverage of protein degraders, molecular glues, and artificial intelligence for early drug discovery. Speakers from industry will once again be strongly represented, including: AbbVie, Amgen, Astex Pharmaceuticals, AstraZeneca, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, EMD Serono, Genentech, GlaxoSmithKline, Janssen, Johnson & Johnson, Merck, Novartis, Pfizer, and more.
Explore current trends, challenges and developments in drug discovery.
Discuss the innovative chemistries and technologies that can be leveraged to induce proximity for mechanistic studies and therapeutic intervention.
Attned keynote sessions and panel discussions to discuss important issues underlying targeted protein degradation as a new therapeutic approach.
Listen to top industry experts and leaders for early drug discovery to understand protein degraders, molecular glues, and artificial intelligence.
Cambridge Healthtech Institute – Your Life Science Network Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries to advance discoveries and deliver groundbreaking treatments to patients.
Pelago Bioscience was founded in 2013 with the aim to develop the patented Cellular Thermal Shift Assay (CETSA®) for maximum utility and customer value in drug discovery and diagnostics.
Liverpool ChiroChem is an international, chemical technology innovator, on a mission to accelerate the discovery and development of high-quality drugs. LCC was established in Liverpool, United Kingdom, in June 2014.
HitGen is a rapidly growing biotech company with headquarters and the main research facility based in Chengdu, China and a subsidiary in the USA.
Founded in 2013, Applied BioMath uses mathematical modeling and simulation to provide quantitative and predictive guidance to biotechnology and pharmaceutical companies to help accelerate and de-risk drug research and development.
Nanome is a software company that is changing the way humanity understands and interacts with science. Using Virtual Reality our technology accelerates innovation and understanding in an intuitive manner.
Immense opportunities are within reach. X-Chem is the partner you need to unlock exponential possibilities in your small molecule drug discovery.
At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems.
We are a quantum physics-based, AI-powered drug R&D company with the mission to revolutionize drug discovery and development by improving the speed, scale, novelty and success rate. With operations in both China and the U.S., we strive to deploy the
We are a quantum physics-based, AI-powered drug R&D company with the mission to revolutionize drug discovery and development by improving the speed, scale, novelty and success rate. With operations in both China and the U.S., we strive to deploy the best capabilities and resources available to us in
SARomics Biostructures provides a broad range of structural biology and drug discovery services that include: FastLane™ Standard and FastLane™ Premium off-the-shelf structures, gene-to-structure services protein NMR spectroscopy fragment screening an
SARomics Biostructures provides a broad range of structural biology and drug discovery services that include: FastLane™ Standard and FastLane™ Premium off-the-shelf structures, gene-to-structure services protein NMR spectroscopy fragment screening and fragment-based drug design computational chemist
Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufactur
Pharmaron (Stock Code: 300759.SZ/3759.HK) is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire dru
PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) is a leading provider of innovative chemistry products & services throughout the pharmaceutical R&D process and commercial production. Its core businesses include: a rationally designed building bloc
PharmaBlock Sciences (Nanjing), Inc. (SZSE:300725) is a leading provider of innovative chemistry products & services throughout the pharmaceutical R&D process and commercial production. Its core businesses include: a rationally designed building blocks (BBs) collection, supplying from discovery, to
OmicScouts integrates quantitative mass spectrometry-based proteomics and bioinformatics with biochemical and cell culture services to advance client's drug discovery, disease biology, and clinical research. OmicScouts' technologies enable unbiased
OmicScouts integrates quantitative mass spectrometry-based proteomics and bioinformatics with biochemical and cell culture services to advance client's drug discovery, disease biology, and clinical research. OmicScouts' technologies enable unbiased and comprehensive identification of drug targets,
All trademarks, registered trademarks, product names, and company names or logos mentioned in or on this site are the property of their respective owners.
A great community. Legit content. The kind of emails you actually look forward to.